{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:05:46Z","timestamp":1790348746569,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Cervical cancer is a highly prevalent cancer that affects women around the world. With the availability of new technologies, researchers have increased their efforts to develop new drug delivery systems in cervical cancer chemotherapy. In this review, we summarized some of the recent research in systematic and localized drug delivery systems and compared the advantages and disadvantages of these methods.<\/jats:p>","DOI":"10.3390\/pharmaceutics8030023","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T09:45:15Z","timestamp":1469007915000},"page":"23","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Drug Delivery Approaches for the Treatment of Cervical Cancer"],"prefix":"10.3390","volume":"8","author":[{"given":"Farideh","family":"Ordikhani","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Erdem Arslan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7481-6406","authenticated-orcid":false,"given":"Raymundo","family":"Marcelo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyas","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA 02138, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Grigsby","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Radiology and Obstetrics and Gynecology, Washington University School of Medicine, Saint Louis, MO 63108, USA"},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA"},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO 63108, USA"},{"name":"Department of Radiation Oncology, Cell Biology and Physiology, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Azab","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Biology Division, Washington University School of Medicine, Saint Louis, MO 63108, USA"},{"name":"Alvin J. Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO 63108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2015.06.009","article-title":"Robotic radical hysterectomy in early stage cervical cancer: A systematic review and meta-analysis","volume":"138","author":"Shazly","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2015.03.029","article-title":"The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice","volume":"93","author":"Zong","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5306\/wjco.v5.i4.775","article-title":"Cervical cancer: Can it be prevented?","volume":"5","author":"Aggarwal","year":"2014","journal-title":"World. J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","article-title":"A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer","volume":"133","author":"Lorusso","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.canep.2015.04.009","article-title":"Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in australia and canada: Results from two large cancer facilities","volume":"39","author":"Kang","year":"2015","journal-title":"Cancer. Epidemiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"New Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajog.2015.07.022","article-title":"Changing paradigms in the systemic treatment of advanced cervical cancer","volume":"214","author":"Pfaendler","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tox.2015.07.010","article-title":"The role of mtor during cisplatin treatment in an in vitro and ex vivo model of cervical cancer","volume":"335","author":"Leisching","year":"2015","journal-title":"Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2011.09.001","article-title":"Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients","volume":"123","author":"Katanyoo","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ejso.2015.04.018","article-title":"Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase ii trial","volume":"41","author":"Wang","year":"2015","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2010.10.020","article-title":"Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase ii trial","volume":"120","author":"Downs","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/gyno.2000.6024","article-title":"A phase ii study of topotecan in patients with squamous cell carcinoma of the cervix: A gynecologic oncology group study","volume":"81","author":"Muderspach","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nlm.2015.05.001","article-title":"Curcumin alleviates cisplatin-induced learning and memory impairments","volume":"123","author":"Oz","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jphotobiol.2014.08.021","article-title":"Synergistic effect of photodynamic therapy and cisplatin: A novel approach for cervical cancer","volume":"140","author":"Soares","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2014.05.005","article-title":"Improved chemosensitivity in cervical cancer to cisplatin: Synergistic activity of mahanine through STAT3 inhibition","volume":"351","author":"Das","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2012.05.047","article-title":"3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells","volume":"162","author":"Yohe","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.17140\/GOROJ-2-106","article-title":"The use of localised vaginal drug delivery as part of a neoadjuvant chemotherapy strategy in the treatment of cervical cancer","volume":"2","author":"McConville","year":"2015","journal-title":"Gynecol. Obstet. Res. Open. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/nnm.14.178","article-title":"Nanobody-based cancer therapy of solid tumors","volume":"10","author":"Kijanka","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.msec.2014.06.002","article-title":"Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: A review","volume":"45","author":"Ye","year":"2014","journal-title":"Mater. Sci. Eng."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomedecine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1016\/j.polymer.2010.10.029","article-title":"Nanoparticle formulation of poly(\u025b-caprolactone-co-lactide)-d-\u03b1-tocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment","volume":"51","author":"Ma","year":"2010","journal-title":"Polymer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfb.2015.07.013","article-title":"Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy","volume":"135","author":"Sun","year":"2015","journal-title":"Colloids Surf. B"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Siepmann, J., Siegel, A.R., and Rathbone, J.M. (2012). Fundamentals and Applications of Controlled Release Drug Delivery, Springer US.","DOI":"10.1007\/978-1-4614-0881-9"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.5858\/133.9.1463","article-title":"Henrietta lacks, hela cells, and cell culture contamination","volume":"133","author":"Lucey","year":"2009","journal-title":"Archiv. Pathol. Lab. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"JNCI J. Nat. Cancer Inst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s11837-015-1626-y","article-title":"The role of biomaterials on cancer stem cell enrichment and behavior","volume":"67","author":"Ordikhani","year":"2015","journal-title":"JOM"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2015.09.017","article-title":"3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma","volume":"73","author":"Muz","year":"2015","journal-title":"Biomate."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2012\/751075","article-title":"Noble metal nanoparticles applications in cancer","volume":"2012","author":"Conde","year":"2012","journal-title":"J. Drug Deliv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2011\/202187","article-title":"Gold nanoparticles: Promising nanomaterials for the diagnosis of cancer and hiv\/aids","volume":"2011","author":"Kumar","year":"2011","journal-title":"J. Nanomater."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/ar7002804","article-title":"Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine","volume":"41","author":"Jain","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/adma.200902557","article-title":"Properties and applications of colloidal nonspherical noble metal nanoparticles","volume":"22","author":"Sau","year":"2010","journal-title":"Adv. Mater."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2014.02.006","article-title":"Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls","volume":"347","author":"Lee","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.biotechadv.2012.10.002","article-title":"Gold nanoparticles: Emerging paradigm for targeted drug delivery system","volume":"31","author":"Kumar","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2009.12.006","article-title":"The forthcoming applications of gold nanoparticles in drug and gene delivery systems","volume":"149","author":"Pissuwan","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.colsurfb.2013.01.027","article-title":"Biogenic silver nanoparticles for cancer treatment: An experimental report","volume":"106","author":"Jeyaraj","year":"2013","journal-title":"Colloids Surf. B"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jcis.2015.07.012","article-title":"Biologically synthesised silver nanoparticles from three diverse family of plant extracts and their anticancer activity against epidermoid a431 carcinoma","volume":"457","author":"Nayak","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jnutbio.2015.06.003","article-title":"Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection\u2014Synthesis, characterization and in vitro evaluation","volume":"26","author":"Mukherjee","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2228-5326-2-32","article-title":"Silver nanoparticles: Mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects","volume":"2","author":"Prabhu","year":"2012","journal-title":"Int. Nano Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.colsurfb.2012.09.042","article-title":"An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using podophyllum hexandrum on human cervical carcinoma cells","volume":"102","author":"Jeyaraj","year":"2013","journal-title":"Colloids Surf. B"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.12968\/jowc.2002.11.4.26389","article-title":"Silver. I: Its antibacterial properties and mechanism of action","volume":"11","author":"Lansdown","year":"2002","journal-title":"J. Wound Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.colsurfb.2014.02.052","article-title":"Anticancer activity of moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction","volume":"117","author":"Vasanth","year":"2014","journal-title":"Colloids Surf. B"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12668-013-0085-6","article-title":"Silver nanoparticles nanocarriers, synthesis and toxic effect on cervical cancer cell lines","volume":"3","year":"2013","journal-title":"BioNanoSci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.msec.2014.03.003","article-title":"Biofabrication of ag nanoparticles using sterculia foetida l. Seed extract and their toxic potential against mosquito vectors and HeLa cancer cells","volume":"39","author":"Rajasekharreddy","year":"2014","journal-title":"Mater. Sci. Eng."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.materresbull.2013.12.060","article-title":"An evidence on G2\/M arrest, DNA damage and caspase mediated apoptotic effect of biosynthesized gold nanoparticles on human cervical carcinoma cells (HeLa)","volume":"52","author":"Jeyaraj","year":"2014","journal-title":"Mater. Res. Bull."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7314\/APJCP.2015.16.1.169","article-title":"Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells","volume":"16","author":"Daduang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.colsurfb.2015.08.036","article-title":"Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines","volume":"135","author":"Tomoaia","year":"2015","journal-title":"Colloids Surf. B"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-8722-5-70","article-title":"Targeted drug delivery for cancer therapy: The other side of antibodies","volume":"5","author":"Firer","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1166\/jbn.2016.2203","article-title":"Aptamer functionalized cisplatin-albumin nanoparticles for targeted delivery to epidermal growth factor receptor positive cervical cancer","volume":"12","author":"Chen","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbcan.2008.03.001","article-title":"Cell-penetrating and cell-targeting peptides in drug delivery","volume":"1786","author":"Vives","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/med.20225","article-title":"Peptide-mediated targeted drug delivery","volume":"32","author":"Majumdar","year":"2012","journal-title":"Med. Res. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/med.21387","article-title":"Small molecules for active targeting in cancer","volume":"36","author":"Kue","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov. Today"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-06-0141","article-title":"Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery","volume":"5","author":"Sinha","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_57","first-page":"10501","article-title":"Promising potency of retinoic acid-poly(ethylene glycol)-thiol gold nanoparticle conjugates for cervical cancer treatment","volume":"8","author":"Ye","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_58","first-page":"1","article-title":"Green synthesis of platinum nanoparticles that induce cell death and G2\/M-phase cell cycle arrest in human cervical cancer cells","volume":"26","author":"Alshatwi","year":"2014","journal-title":"J. Mater. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tox.2013.08.018","article-title":"Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(ii) complex against human cervical cancer","volume":"314","year":"2013","journal-title":"Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2014.10.016","article-title":"Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles","volume":"69","author":"Dixit","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","article-title":"Cholic acid-functionalized nanoparticles of star-shaped P-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomater."},{"key":"ref_62","first-page":"74","article-title":"Role of biodegradable polymers in drug delivery","volume":"4","author":"JOSHI","year":"2012","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1166\/jnn.2009.J065","article-title":"Poly(d,l-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: Preparation, release kinetics and anticancer effect","volume":"9","author":"Yang","year":"2009","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-7-666","article-title":"Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer","volume":"7","author":"Qiu","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11671-010-9620-3","article-title":"Nanoparticles of poly(lactide-co-glycolide)-d-a-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment","volume":"5","author":"Ma","year":"2010","journal-title":"Nanoscale Res. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bionut.2011.09.003","article-title":"Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells","volume":"1","author":"Krishnakumar","year":"2011","journal-title":"Biomed. Prev. Nutr."},{"key":"ref_67","first-page":"2461","article-title":"Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3109\/10717544.2015.1122675","article-title":"Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: Optimization and in vivo antitumor activity","volume":"23","author":"Zhang","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1021\/mp300221f","article-title":"The interactions between l-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow","volume":"9","author":"Ditto","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1039\/C4TB02146K","article-title":"Rational design and fabrication of a cancer-targeted chitosan nanocarrier to enhance selective cellular uptake and anticancer efficacy of selenocystine","volume":"3","author":"Yu","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ji, J., Zuo, P., and Wang, Y.L. (2015). Enhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles. Nanoscale Res. Lett.","DOI":"10.1186\/s11671-015-1162-2"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1166\/jnn.2015.10752","article-title":"Stability, pharmacokinetics, biodistribution and safety assessment of folate-conjugated pullulan acetate nanoparticles as cervical cancer targeted drug carriers","volume":"15","author":"Tang","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2014.12.023","article-title":"A novel approach for the intravenous delivery of leuprolide using core-cross-linked polymeric micelles","volume":"205","author":"Hu","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urolonc.2007.03.015","article-title":"Nanoparticles for drug delivery in cancer treatment","volume":"26","author":"Haley","year":"2008","journal-title":"Urol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11095-006-9223-y","article-title":"Functionalized micellar systems for cancer targeted drug delivery","volume":"24","author":"Sutton","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_76","first-page":"656","article-title":"Anti-tumor activity of biodegradable polymer-paclitaxel conjugated micelle against mice U14 cervical cancers","volume":"28","author":"Chen","year":"2012","journal-title":"Chem. Res. Chin. Univ."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/00914037.2015.1038819","article-title":"Charge-conversional binary drug delivery polymeric micelles for combined chemotherapy of cervical cancer","volume":"64","author":"Guo","year":"2015","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.nano.2015.03.006","article-title":"Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics","volume":"11","author":"Movahedi","year":"2015","journal-title":"Nanomedecine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2014.03.036","article-title":"Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells","volume":"118","author":"Saini","year":"2014","journal-title":"Colloids Surf. B"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2013.08.041","article-title":"Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer","volume":"131","author":"Casagrande","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.colsurfb.2013.10.005","article-title":"Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy","volume":"114","author":"Saengkrit","year":"2014","journal-title":"Colloids Surf. B"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.colsurfb.2014.10.024","article-title":"Transferrin conjugated poly(\u03b3-glutamic acid-maleimide-co-l-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery","volume":"123","author":"Zhao","year":"2014","journal-title":"Colloids Surf. B"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2016.05.023","article-title":"Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid","volume":"105","author":"Sriraman","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mattod.2015.06.003","article-title":"Pamam dendrimers as promising nanocarriers for RNAi therapeutics","volume":"18","author":"Kesharwani","year":"2015","journal-title":"Mater. Today"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1021\/bm400626w","article-title":"Self-adjuvanting polymer\u2013peptide conjugates as therapeutic vaccine candidates against cervical cancer","volume":"14","author":"Liu","year":"2013","journal-title":"Biomacromol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jpcb.5b11125","article-title":"Il-6 antibody and RGD peptide conjugated poly(amidoamine) dendrimer for targeted drug delivery of HeLa cells","volume":"120","author":"Mekuria","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Benita","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1208\/s12248-012-9398-6","article-title":"Characterising lipid lipolysis and its implication in lipid-based formulation development","volume":"14","author":"Thomas","year":"2012","journal-title":"AAPS J."},{"key":"ref_91","first-page":"69","article-title":"Formulation and characetization of self-microemulsifying drug delivery systems according to their cytotoxic attributes","volume":"84","author":"Ujhelyi","year":"2014","journal-title":"Acta. Pharm. Hung."},{"key":"ref_92","first-page":"42","article-title":"Self emulsifying drug delivery system (SEDDS): A review","volume":"2","author":"Nigade","year":"2012","journal-title":"Int. J. of Pharm. Biol. Sci."},{"key":"ref_93","first-page":"7","article-title":"Self emulsifying drug delivery system (SEDDS): Future aspects","volume":"2","author":"Kumar","year":"2010","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.3390\/molecules200713226","article-title":"The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer hela cells","volume":"20","author":"Ujhelyi","year":"2015","journal-title":"Molecules"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"90295","DOI":"10.1039\/C5RA18112G","article-title":"Self-microemulsifying drug delivery system of curcumin with enhanced solubility and bioavailability using a new semi-synthetic bicephalous heterolipid: In vitro and in vivo evaluation","volume":"5","author":"Dhumal","year":"2015","journal-title":"RSC Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.bmcl.2014.10.021","article-title":"Antibody\u2013drug conjugates\u2014A new wave of cancer drugs","volume":"24","author":"Bouchard","year":"2014","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ducry, L. (2013). Antibody-drug conjugates, Humana Press.","DOI":"10.1007\/978-1-62703-541-5"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Peters, C., and Brown, S. (2015). Antibody\u2013drug conjugates as novel anti-cancer chemotherapeutics. Biosci. Rep.","DOI":"10.1042\/BSR20150089"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/mabs.27022","article-title":"Site-specific antibody drug conjugates for cancer therapy","volume":"6","author":"Panowski","year":"2014","journal-title":"mAbs"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-13-2440","article-title":"An antibody\u2013drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors","volume":"74","author":"Breij","year":"2014","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Bardia, A., Starodub, A., Moroose, R.L., Mayer, I.A., Diamond, J.R., Chuang, E., Govindan, S.V., Sharkey, R.M., Maliakal, P., and Wegener, W.A. (2015). Abstract p5-19-27: Immu-132, a new antibody-drug conjugate (ADC) against Trop-2, as a novel therapeutic for patients with relapsed\/refractory, metastatic, triple-negative breast cancer (TNBC): Results from phase I\/II clinical trial (nct01631552). Cancer Res.","DOI":"10.1158\/1538-7445.SABCS14-P5-19-27"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"22496","DOI":"10.18632\/oncotarget.4318","article-title":"Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (immu-132), an antibody-drug conjugate (ADC)","volume":"6","author":"Goldenberg","year":"2015","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-015-0440-6","article-title":"Adenocarcinoma of the cervix: Should we treat it differently?","volume":"17","author":"Williams","year":"2015","journal-title":"Curr. Oncol. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2006.08.014","article-title":"Cervical cancer treatment with a locally insertable controlled release delivery system","volume":"115","author":"Keskar","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.antiviral.2013.09.022","article-title":"Electrospun fibers for vaginal anti-HIV drug delivery","volume":"100","author":"Blakney","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: A review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ejpb.2014.08.002","article-title":"Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer","volume":"88","author":"Boyd","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2014.04.018","article-title":"Electrospinning of polymeric nanofibers for drug delivery applications","volume":"185","author":"Hu","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Li, S.F., Liu, D.X., Zheng, Y.H., Yue, Y., Huang, Y.B., and Jing, X.B. (2012). Inhibitory effects of paclitaxel-loaded PLA nanofibers against mice cervical cancers. Acta Polym. Sin., 1029\u20131034.","DOI":"10.3724\/SP.J.1105.2012.12066"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1166\/jbt.2014.1235","article-title":"Preparation and optimization of curcumin-hydroxy propyl \u03b2 cyclodextrin bioadhesive vaginal films for human papilloma virus-induced cervical cancer","volume":"4","author":"Hani","year":"2014","journal-title":"J. Biomater. Tissue Eng."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10847-006-9259-y","article-title":"Thermosensitive mucoadhesive gel formulation loaded with 5-fu: Cyclodextrin complex for HPV-induced cervical cancer","volume":"57","author":"Bilensoy","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0168-3659(95)00018-4","article-title":"A bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue","volume":"35","author":"Woolfson","year":"1995","journal-title":"J. Control. Release"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(97)04888-6","article-title":"Cytotoxicity of 5-fluorouracil released from a bioadhesive patch into uterine cervical tissue","volume":"151","author":"McCarron","year":"1997","journal-title":"Int. J. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2012.07.097","article-title":"Localized delivery of chemotherapy to the cervix for radiosensitization","volume":"127","author":"Hodge","year":"2012","journal-title":"Gynecol. Oncol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/8\/3\/23\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:26:37Z","timestamp":1760210797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/8\/3\/23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["pharmaceutics8030023"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics8030023","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]}}}